Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis
NCT01517594 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 568
Last updated 2013-10-21
Summary
Confirmation of safety profile
Conditions
Sponsors & Collaborators
-
Ferring Pharmaceuticals
lead INDUSTRY
Principal Investigators
-
Clinical Development Support · Ferring Pharmaceuticals
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-10-31
- Primary Completion
- 2013-06-30
- Completion
- 2013-06-30
Countries
- Czechia
Study Locations
More Related Trials
-
Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis
NCT01538251 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis
NCT04596293 ·Status: COMPLETED ·Phase: PHASE2
-
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
NCT02914535 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of MK-6194 (PT101) in Participants With Active Ulcerative Colitis (UC) (MK-6194-002)
NCT04924114 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of PBF-677 in Ulcerative Colitis Patients
NCT03773952 ·Status: COMPLETED ·Phase: PHASE2
-
Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerability Study
NCT01567956 ·Status: TERMINATED ·Phase: PHASE3
-
Clinical Study to Evaluate the Possible Efficacy and Safety of Febuxostat in Patients With Ulcerative Colitis Treated With Mesalamine
NCT06525974 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment
NCT02261636 ·Status: COMPLETED
-
A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis
NCT00928681 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis
NCT02895100 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis.
NCT00151944 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease
NCT00225810 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Ozanimod in Ulcerative Colitis
NCT01647516 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis
NCT01039597 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis
NCT01829321 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)
NCT01562314 ·Status: COMPLETED ·Phase: PHASE2
-
An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase
NCT02368717 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)
NCT07265570 ·Status: RECRUITING ·Phase: PHASE2
-
The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis
NCT03178669 ·Status: COMPLETED ·Phase: PHASE2
-
Iron Supplementation in Inflammatory Bowel Disease (IBD) Patients With Chronic Fatigue
NCT02517151 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
NCT06979336 ·Status: RECRUITING ·Phase: PHASE2
-
Phase II Study of HMPL-004 in Patients With Ulcerative Colitis
NCT00659802 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative Colitis
NCT05382715 ·Status: TERMINATED
-
Boosting Biologics in UC
NCT04241029 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis
NCT03934216 ·Status: COMPLETED ·Phase: PHASE2